Dr. Kim Dong-Wook                  CML                    Chronic Myeloid Leukemia

Dr. Dong-Wook Kim, MD. PhD
Professor, Division of Hematology, St. Mary’s Hospital, The Catholic University of Korea;
Director, Molecular Genetic Research Laboratoy, Catholic Medical Science Institute, The Catholic University of Korea;
Director, Asia-Pacific Central Referral
Laboratory of Novartis Global Clinical Trials:

''A research team at Seoul St. Mary's Hospital's hematopoetic stem cell transplant center, led by professor Kim Dong-Wook, administered the new medicine, named Supect (IY5511), to 22 chronic myeloid leukemia patients from July 2008''... Extract from Youhp

CML update from 2011 ASH annual meeting
December 14, 2011, Biotech Strategy Blog

Recent advances in the path toward the cure for chronic myeloid leukemia
September 30, 2011, The Korean Journal of Hematology
 
Dr. Kim Dong-Wook, has been selected as the first Asian panelist of the European Leukemia Net
October 10, 2010,  Medical Korea

New Leukemia Drug Shows Promise
July 30, 2009, Korea Times

Interview with Dr. Kim Dong-Wook
September 2006, CMLIinfo.org